ERBB2 and neoplasm: The level of complexity for the role of Notch signalling in the tumour microenvironment requires a thorough investigation of the Notch pathway in breast cancer, and most notably in anti-ErbB-2-targeted drug resistance, with the goal of identifying novel and specific targets to treat or reverse resistance.